Polymerised autologous tumor tissue particles in experimental cancer immunotherapy with special reference to the effects on the immune system of the host.

The efficacy of the specific active cancer immunotherapy utilizing autologous tumor tissue particles polymerised with ethylchlorformiate, and used in combination with the PPD tuberculin adjuvant, was studied in the mastocytoma (P-815 X2)-DBA/2 mouse system. Special attention was focused on the effects of the therapy on the immune system of the host as… CONTINUE READING